ACCESS 2 IMMUNOASSAY SYSTEM 81600N

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2009-01-30 for ACCESS 2 IMMUNOASSAY SYSTEM 81600N manufactured by Beckman Coulter, Inc..

Event Text Entries

[17144989] A customer contacted beckman coulter inc. (bci) regarding a lower than expected result for inhibin a that was generated by the access 2 instrument for one pt. The initial inhibin a result was 25. 0pg/ml. The result was not reported out of the lab. The original sample was re-tested twice and results of 104. 7pg/ml and 102. 3pg/ml were obtained, respectively. The result of 102. 3pg/ml was reported out of the lab. There was no effect to pt treatment in connection with this event.
Patient Sequence No: 1, Text Type: D, B5


[17318207] The sample was collected in a serum tube and it was centrifuged at 3,500 rpm for 10 minutes. This is the only result and assay in question at this time. Qc was recovering within expected ranges prior to and on the day of event. A system check performed on 01/12/09 was within the published specifications. A field service engineer (fse) was dispatched: the fse replaced the transducer. The fse verified the repair per established procedures, and results met published performance specifications. Per fse, the transducer voltage was not holding at the correct reading while sonicating the particles while aspirating. It was intermittent which could explain why not all testing was affected. Also, not all assays are sensitive to sonicating problems. The fse stated this issue was the root cause for this event. Even though the low inhibin a result obtained is unlikely to be the basis to initiate or withhold treatment, in this event the hardware failure may have affected other pivotal assays. Erroneous results of a pivotal assay may contribute to serious injury to the pt. Hardware issue addressed by the fse likely contributed to this event. A malfunction will be assumed for the purpose of this report. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2122870-2009-00035
MDR Report Key1369584
Report Source05
Date Received2009-01-30
Date of Report2009-01-30
Date of Event2009-01-09
Date Mfgr Received2009-01-13
Device Manufacturer Date2007-05-01
Date Added to Maude2010-01-07
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactNORA ZEROUNIAN, GROUP MGR
Manufacturer Street200 S. KRAEMER BLVD. PO BOX 8000, MAIL STOP: W-110
Manufacturer CityBREA CA 928228000
Manufacturer CountryUS
Manufacturer Postal928228000
Manufacturer Phone7149613634
Single Use3
Remedial ActionRL
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameACCESS 2 IMMUNOASSAY SYSTEM
Generic NameDISCRETE PHOTOMETRIC CHEMISTRY ANALYZER
Product CodeNDR
Date Received2009-01-30
Model NumberACCESS 2 IMMUNOASSAY SYSTEM
Catalog Number81600N
Lot NumberNA
OperatorHEALTH PROFESSIONAL
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerBECKMAN COULTER, INC.
Manufacturer Address1000 LAKE HAZELTINE DR. CHASKA MN 55318 US 55318


Patients

Patient NumberTreatmentOutcomeDate
10 2009-01-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.